Literature DB >> 9648057

Graves' disease after percutaneous ethanol injection for the treatment of autonomous thyroid adenoma.

G Verde.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9648057     DOI： 10.1007/BF03350338

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  10 in total

1.  Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves' disease.

Authors:  P Vitti; T Rago; F Mancusi; S Pallini; M Tonacchera; F Santini; L Chiovato; C Marcocci; A Pinchera
Journal:  Acta Endocrinol (Copenh)       Date:  1992-02

2.  Appearance of Graves' disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma.

Authors:  F Monzani; P Del Guerra; N Caraccio; A Casolaro; P V Lippolis; O Goletti
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

3.  Appearance of Graves'-like disease after radioiodine therapy for toxic as well as non-toxic multinodular goitre.

Authors:  B Nygaard; J Faber; A Veje; L Hegedüs; J M Hansen
Journal:  Clin Endocrinol (Oxf)       Date:  1995-07       Impact factor: 3.478

4.  Graves' disease with functioning nodules (Marine-Lenhart syndrome).

Authors:  N D Charkes
Journal:  J Nucl Med       Date:  1972-12       Impact factor: 10.057

5.  Sequential presentation of a case of hyperthyroidism with autonomously functioning nodules and Graves' disease in the presence of IgG thyroid stimulators.

Authors:  P P Smyth; D Neylan; N M McMullan; D F Smith; T J McKenna
Journal:  Acta Endocrinol (Copenh)       Date:  1988-08

6.  Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study Group.

Authors:  F Lippi; C Ferrari; L Manetti; T Rago; F Santini; F Monzani; P Bellitti; E Papini; B Busnardo; F Angelini; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

7.  Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.

Authors:  B Nygaard; J H Knudsen; L Hegedüs; A V Scient; J E Hansen
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

8.  Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.

Authors:  L Chiovato; F Santini; P Vitti; G Bendinelli; A Pinchera
Journal:  Clin Endocrinol (Oxf)       Date:  1994-06       Impact factor: 3.478

9.  Percutaneous ethanol injection (PEI): what is its role in the treatment of benign thyroid nodules?

Authors:  E Papini; C M Pacella; G Verde
Journal:  Thyroid       Date:  1995-04       Impact factor: 6.568

10.  Unusual events preceding hyperthyroidism with diffuse goiter.

Authors:  R Bendezu; R G Wieland; P Tang; B Levine
Journal:  Arch Intern Med       Date:  1977-08
  10 in total
  2 in total

1.  Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay.

Authors:  Simone Dunkelmann; Ricarda Wolf; Annedore Koch; Christian Kittner; Peter Groth; Carl Schuemichen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-19       Impact factor: 9.236

2.  Graves Disease Induced by Radioiodine Therapy for Toxic Nodular Goiter: A Case Report.

Authors:  Yakup Yürekli; Arzu Cengiz; Engin Güney
Journal:  Mol Imaging Radionucl Ther       Date:  2015-10-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.